215 related articles for article (PubMed ID: 31450925)
1. Gene Combination of CD44 rs187116, CD133 rs2240688, NF-κB1 rs28362491 and GSTM1 Deletion as a Potential Biomarker in Risk Prediction of Breast Cancer in Lower Northern Thailand.
Sapcharoen K; Sanguansermsri P; Yasothornsrikul S; Muisuk K; Srikummool M
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2493-2502. PubMed ID: 31450925
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of cancer stem cell marker gene CD133 are associated with susceptibility and prognosis of gastric cancer.
Jia ZF; Wu YH; Cao DH; Cao XY; Jiang J; Zhou BS
Future Oncol; 2017 May; 13(11):979-989. PubMed ID: 28326835
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of the Stem Cell Marker Gene CD133 and the Risk of Lung Cancer in Chinese Population.
Liu QF; Zhang ZF; Hou GJ; Yang GY; He Y
Lung; 2016 Jun; 194(3):393-400. PubMed ID: 27130457
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in inflammatory response genes and their associations with breast cancer risk.
Wang Z; Liu QL; Sun W; Yang CJ; Tang L; Zhang X; Zhong XM
Croat Med J; 2014 Dec; 55(6):638-46. PubMed ID: 25559835
[TBL] [Abstract][Full Text] [Related]
5. GSTM1, GSTT1 and GSTP1 in patients with multiple breast cancers and breast cancer in association with another type of cancer.
Chirilă DN; Bălăcescu O; Popp R; Oprea A; Constantea NA; Vesa S; Ciuce C
Chirurgia (Bucur); 2014; 109(5):626-33. PubMed ID: 25375048
[TBL] [Abstract][Full Text] [Related]
6. The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.
Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S
Cancer Biomark; 2016; 16(1):109-15. PubMed ID: 26835711
[TBL] [Abstract][Full Text] [Related]
7. GSTM1 and GSTT1 Genetic Polymorphisms and Breast Cancer Risk in Selected Filipino Cases.
Kalacas NA; Garcia JA; Sy Ortin T; Valdez Jr A; Fellizar A; Ramos MC; Albano PM
Asian Pac J Cancer Prev; 2019 Feb; 20(2):529-535. PubMed ID: 30803216
[TBL] [Abstract][Full Text] [Related]
8. Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
Stotz M; Herzog SA; Pichler M; Smolle M; Riedl J; Rossmann C; Bezan A; Stöger H; Renner W; Berghold A; Gerger A
Anticancer Res; 2017 Apr; 37(4):2011-2018. PubMed ID: 28373475
[TBL] [Abstract][Full Text] [Related]
9. [Association of CD44 polymorphisms with genetic susceptibilities and clinico-pathologic characteristics in breast cancer].
Zhou X; Wu CY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):807-11. PubMed ID: 23387202
[TBL] [Abstract][Full Text] [Related]
10. Allelotype influence at glutathione S-transferase M1 locus on breast cancer susceptibility.
Charrier J; Maugard CM; Le Mevel B; Bignon YJ
Br J Cancer; 1999 Jan; 79(2):346-53. PubMed ID: 9888479
[TBL] [Abstract][Full Text] [Related]
11. Association of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer Patients.
Bitaraf SM; Mahmoudian RA; Abbaszadegan M; Mohseni Meybodi A; Taghehchian N; Mansouri A; Forghanifard MM; Memar B; Gholamin M
Asian Pac J Cancer Prev; 2018 May; 19(5):1313-1318. PubMed ID: 29802692
[TBL] [Abstract][Full Text] [Related]
12. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.
Saxena A; Dhillon VS; Raish M; Asim M; Rehman S; Shukla NK; Deo SV; Ara A; Husain SA
Breast Cancer Res Treat; 2009 Jun; 115(3):537-43. PubMed ID: 18574688
[TBL] [Abstract][Full Text] [Related]
13. A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.
Spurdle AB; Chang JH; Byrnes GB; Chen X; Dite GS; McCredie MR; Giles GG; Southey MC; Chenevix-Trench G; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):769-74. PubMed ID: 17416769
[TBL] [Abstract][Full Text] [Related]
14. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
15. CD44 gene polymorphisms in breast cancer risk and prognosis: a study in North Indian population.
Tulsyan S; Agarwal G; Lal P; Agrawal S; Mittal RD; Mittal B
PLoS One; 2013; 8(8):e71073. PubMed ID: 23940692
[TBL] [Abstract][Full Text] [Related]
16. Significant association between rs28362491 polymorphism in NF-κB1 gene and coronary artery disease: a meta-analysis.
Wang Y; Wu B; Zhang M; Miao H; Sun J
BMC Cardiovasc Disord; 2020 Jun; 20(1):278. PubMed ID: 32513188
[TBL] [Abstract][Full Text] [Related]
17. Allelic deletion at glutathione S-transferase M1 locus and its association with breast cancer susceptibility.
Maugard CM; Charrier J; Bignon YJ
Chem Biol Interact; 1998 Apr; 111-112():365-75. PubMed ID: 9679567
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase M1 gene polymorphism in Thai nasopharyngeal carcinoma.
Tiwawech D; Srivatanakul P; Karalak A; Ishida T
Asian Pac J Cancer Prev; 2005; 6(3):270-5. PubMed ID: 16235985
[TBL] [Abstract][Full Text] [Related]
19. A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer.
Yu KD; Di GH; Fan L; Wu J; Hu Z; Shen ZZ; Huang W; Shao ZM
FASEB J; 2009 Jul; 23(7):2274-87. PubMed ID: 19228880
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the stem cell marker gene
Liu QF; Zhang ZF; Hou GJ; Yang GY; He Y
BMJ Open; 2017 Aug; 7(8):e016913. PubMed ID: 28827262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]